Twinlab facility
This article was originally published in The Tan Sheet
Executive Summary
Manufacturing of private label and Bronson catalog products will be shifted internally, outsourced or discontinued in light of firm's plans to close or sell its Tempe, Ariz. plant. Branded products are manufactured at plants in New York, Utah and will not be affected, Twinlab says March 4. Shift from manufacturing at Arizona site, which will be phased in over the next few months, will help "streamline operations, increase productivity" and cost-effectiveness, Twinlab says. Ultimately, 12% of firm's workforce, mostly at production level, will be eliminated by the action...
You may also be interested in...
Twinlab Manufacturing Facility To Be Bought By Anabolic Labs
Anabolic Labs expects its acquisition of Twinlab's Health Factors International manufacturing facility to close by the beginning of May
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.